ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

CUSIP: 82835W108

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
98,883,573
Total 13F shares
76,226,291
Share change
+4,927,610
Total reported value
$958,937,759
Put/Call ratio
215%
Price per share
$12.58
Number of holders
182
Value change
+$63,838,841
Number of buys
96
Number of sells
74

Quarterly Holders Quick Answers

What is CUSIP 82835W108?
CUSIP 82835W108 identifies SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q1 2025

As of 31 Mar 2025, ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) was held by 182 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 76,226,291 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, BlackRock, Inc., SR One Capital Management, LP, ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, STATE STREET CORP, FRANKLIN RESOURCES INC, and Cormorant Asset Management, LP. This page lists 182 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.